Skip to main content
Need Help?
CME and General Info
Purchase Access
CE and Evaluations
What Others Learned
FAQs
Help
On Demand Sessions
Full Schedule
Browse by Title
Browse by Track
Browse by Faculty
Sponsored Programs
Product Showcase
Browse by Product Name
Browse by Company Name
Sponsors
Exhibits
Browse by Company
Logo Wall
On Demand Purchase
Faculty
Abstracts and Posters
How to View
Browse by Title
ePoster Gallery
My Agenda
Login required
Evaluation
Login required
Toggle navigation
Login
Search
Home
Need Help?
CME and General Info
Purchase Access
CE and Evaluations
What Others Learned
FAQs
Help
On Demand Sessions
Full Schedule
Browse by Title
Browse by Track
Browse by Faculty
Sponsored Programs
Product Showcase
Browse by Product Name
Browse by Company Name
Sponsors
Exhibits
Browse by Company
Logo Wall
On Demand Purchase
Faculty
Abstracts and Posters
How to View
Browse by Title
ePoster Gallery
My Agenda
Login required
Evaluation
Login required
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove.
Home
Browse Posters
Browse Posters
Browse Posters
Type here to filter the list
Sort by
#
Sort by
Title
1
Nonmedical Use of Xtampza ER versus Other Oxycodone-Containing Products
Favorite
2
Perception of XTAMPZA® ER and other abuse-deterrent opioid formulations on the internet
Favorite
3
Diversion and street price of XTAMPZA® ER relative to other prescription opioids
Favorite
4
Abuse of XTAMPZA® ER relative to other opioid analgesics
Favorite
5
Abuse of tapentadol among individuals entering treatment for opioid use disorder
Favorite
6
Acute Treatment Optimization Influences Disability and Quality of Life in Migraine: Results of the ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) study
Favorite
7
Neuronal Effects of Music Entrainment versus Preferred Music in Three Patients with Chronic Cancer Pain as Measured via EEG and LORETA Imaging
Favorite
8
Spinal Cord Stimulation for Chronic Knee Pain After Knee Replacement Surgery: A Case Series
Favorite
9
Remote electrical neuromodulation for acute treatment of migraine in people with chronic migraine: a pooled analysis of efficacy and safety
Favorite
10
Efficacy of Galcanezumab in Adults with Treatment Resistant Migraine and Concomitant Pain Disorders: Post-hoc Subpopulation Analyses from the Randomized, Double-Blind, Placebo-Controlled CONQUER Study
Favorite
11
Properties of thermal analgesia in a human chronic low back pain model
Favorite
12
Thermal analgesia, exploring the boundary between pain relief and nociception
Favorite
13
Assessment of thermal safety of a new medical device using high energy pulsed heat: A novel standardized approach
Favorite
14
Buprenorphine Buccal Film in Patients With Chronic Low Back Pain: A Pooled Subgroup Analysis of Two Double-Blind, Placebo-Controlled, Randomized Withdrawal Trials by Baseline Pain Severity
Favorite
15
Retrospective Chart Review of Advanced Practice Pharmacist Prescribing of Controlled Substances for Pain Management in Veterans
Favorite
16
An Exploration of the Implications of Sequencing Order on Group Pain Interventions
Favorite
17
The Effect of Covid-19 on the Opioid Epidemic: A retrospective review investigating the changes in opioid consumption in chronic pain patients unable to undergo their interventional pain procedure during the Covid-19 pandemic
Favorite
18
Complex Regional Pain Syndrome Treated With Combined Stellate Ganglion and Axillary Approach Brachial Plexus Blocks - A Case Series
Favorite
19
Consensus Recommendations on Dosing and Administration of Medical Cannabis to Treat Chronic Pain: Results of a Modified Delphi Process
Favorite
20
10 kHz Spinal Cord Stimulation for Treatment of Painful Diabetic Neuropathy - A Multicenter Randomized Controlled Trial
Favorite
21
Assessment of Students’ Knowledge, Skills and Attitudes after Comprehensive Pain Assessment Training
Favorite
22
Efficacy and safety of NTM-006 in a randomized, double-blind, placebo- and active-controlled trial in moderate to severe pain after third molar extraction. Meaningful and sustained analgesia over 24h demonstrated for a single dose (1000 mg) of NTM-006, an NCE with a novel non-opioid/non-NSAID mechanism of action.
Favorite
23
Symptomatically Severe Secondary Fibromyalgia, Tertiary Fibromyalgia, Therapeutic Clinical Resistance & PTSD
Favorite
24
Clinically Meaningful Results with Voltaren® Arthritis Pain (Topical Diclofenac Sodium 1%), a Non-surgical Treatment Option for Osteoarthritis of the Knee
Favorite
25
Reductions in Pain, Increased Function, and Improved Quality of Life After Use of a Topical Analgesic Pain Relieving Patch: Results from the RELIEF Study
Favorite
26
The Crisis Within the Crisis: Fentanyl Abuse and COVID-19
Favorite
27
Effects of Induction and Maintenance Ketamine Infusions in CRPS Patients
Favorite
28
The Use of External Neuromodulation in a Community Chronic Pain Service
Favorite
29
A retrospective comparison of postpartum oral morphine equivalent (OME) requirements in pregnant individuals treated with buprenorphine or methadone for opioid use disorder (OUD)
Favorite
30
Nonpharmaceutical Fentanyl Analogs in the Illicit Drug Trade: Where are We Heading?
Favorite
31
What is the Role of Buprenorphine in the Era of Abuse Deterrent Formulations?
Favorite
32
Exploring the Connections Between Sleep and Cluster Headache
Favorite
33
Medication-Assisted Therapy for Opioid Use Disorder: A Review of Established Treatments and New Directions
Favorite
34
COVID-19 and NSAIDs: Knowns and Unknowns
Favorite
35
Four Pandemics: Lessons Learned, Lessons Lost
Favorite
36
Ibuprofen Safety: A Look Back on 50 Years
Favorite
37
Clinically Meaningful Responses to Fremanezumab in Migraine Patients With Medication Overuse and Documented Inadequate Response to 2-4 Migraine Preventive Medications in the Randomized, Placebo-controlled FOCUS Study
Favorite
38
Impact of Fremanezumab on Any Acute Headache Medication Use in Migraine Patients With Medication Overuse and Documented Inadequate Response to 2-4 Migraine Preventive Medication Classes in the Multicenter, Randomized, Placebo-controlled FOCUS Study
Favorite
39
Early Onset of Efficacy With Fremanezumab in Patients With Medication Overuse and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Treatments: Subgroup Analysis of the Randomized, Double-blind FOCUS Study
Favorite
40
Efficacy of Fremanezumab in Migraine Patients with Medication Overuse and Documented Inadequate Response to 2-4 Migraine Preventive Medication Classes: Subgroup Analysis of the Randomized, Placebo-controlled FOCUS Study
Favorite
41
Characterizing patients after opioid taper in a VA Medical Center
Favorite
42
Long-term treatment with capsaicin 8% patches: a subgroup analysis in patients with postherpetic neuralgia from an open-label study
Favorite
43
Treatment outcomes in patients with postherpetic neuralgia: a controlled trial of capsaicin 8% patch versus oral pregabalin
Favorite
44
Treatment outcomes in patients with Post-Surgical Neuropathic Pain (PSNP): data from a randomized controlled clinical trial comparing high concentration capsaicin patch with pregabalin
Favorite
45
Is repeat treatment with high concentration capsaicin patch beneficial in patients with peripheral neuropathic pain who did not respond after a first treatment?
Favorite
46
Ketamine Metabolites in the Treatment of Neuropathic Pain
Favorite
47
Reductions in All-Cause Mortality Associated With the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis
Favorite
48
Benefit of Buprenorphine Buccal Film Versus Oral Oxycodone Hydrochloride on Respiratory Drive: A Phase 1 Placebo-Controlled Trial
Favorite
49
The Pharmacodynamics and Pharmacokinetics of Buprenorphine Buccal Film Versus Oral Oxycodone Hydrochloride: Results of a Phase 1 Placebo-Controlled Trial
Favorite
50
Secondary Outcomes of a Phase 1 Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride on Respiratory Drive
Favorite
51
Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Effects on Pupillometry in a Phase I Placebo-Controlled Trial
Favorite
52
Can the Implementation of the CDC’s Opioid Guidelines by Providers Decrease Opioid Misuse among Patients in 2 months?
Favorite
53
Assessing Conversion to Transdermal Fentanyl (TDF) or Methadone During Transition on Hospice Admission
Favorite
54
Delphi Study of Opioid Stewardship Programs in Hospice Setting
Favorite
55
Opioid Stewardship MATters: Addressing Opioid Use Disorder across the Continuum of Care
Favorite
56
Efficacy of Subcutaneous Tanezumab for the Treatment of Osteoarthritis Across Body Mass Index Groups: A Subgroup Analysis of Pooled Data from Two Randomized, Placebo-Controlled Trials
Favorite
57
Not Another Opioid Crisis: Assessing Pharmacists’ Knowledge and Attitudes About Opioid Use for Pain Management and Palliative Care
Favorite
58
Cumulative Laxation Response With Methylnaltrexone: Implications for Hospitalized Patients With Advanced Illness and Opioid-Induced Constipation
Favorite
59
Kyphoplasty and Vertebroplasty: A Systematic Review of 26 Clinical Studies for Height Restoration in Osteoporotic Vertebral Compression Fractures.
Favorite
60
Concern About Addiction is Associated with Lower Quality of Life in Patients with Osteoarthritis: An Observational Data Analysis
Favorite
61
Treatment patterns of patients with moderate-to-severe osteoarthritis in the United States
Favorite
62
The impact of pain severity on treatment patterns, adherence and healthcare resource utilization among individuals with osteoarthritis in the United States.
Favorite
63
Long-term Cardiovascular Safety of Lasmiditan for the Acute Treatment of Migraine For Up to One Year: Interim Results of an Open-Label Phase 3 Study (GLADIATOR)
Favorite
64
A prospective evaluation of clinical and psychologic factors on extended postoperative opioid use after primary total joint arthroplasty.
Favorite
65
Tolperisone 100 and 200 mg Three Times Daily (TID) for Acute Muscle Spasm of the Back: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase 3 Study
Favorite
66
Adverse Events Associated with Analgesics Used for Osteoarthritis Pain: Analysis of Post-Marketing Data
Favorite
67
Creation and Validation of Algorithms to Identify Patients with Moderate-to-Severe Osteoarthritis of the Hip and/or Knee and Inadequate/Intolerable Response to Multiple Pain Medications
Favorite
68
Ubrogepant is Effective in the Acute Treatment of Migraine with Mild Pain
Favorite
69
Summary of the Preclinical Pharmacology of NTM-006 (formerly JNJ-10450232): A Novel Orally-Active Non-Opioid Analgesic
Favorite
70
Identifying Barriers to Care-seeking, Diagnosis, and Preventive Medication Among Those With Migraine: Results of the OVERCOME Study
Favorite
71
Real-World Outcomes from High-Dose Transcutaneous Electrical Nerve Stimulation in Individuals With Chronic Knee Pain
Favorite
72
Telehealth in Pain Medicine: Lessons Learned During the COVID-19 Pandemic
Favorite
73
A long term, open label study of Safety and Tolerability Of Precision olfactory delivery of DHE in acute migraine (STOP 301): Clinical Results
Favorite
74
A Case Report of Pain Management in Calciphylaxis Associated with End Stage Renal Disease
Favorite
75
Tolperisone for Acute Muscle Spasm: Dose-Ranging STAR Study
Favorite
76
Efficacy of Subcutaneous Tanezumab for the Treatment of Osteoarthritis Across Age Groups: A Subgroup Analysis of Pooled Data from Two Randomized, Placebo-Controlled Trials
Favorite
77
Patient Acceptability of a novel upper nasal delivery system for DHE – using the Precision Olfactory Delivery (POD®) device (INP104)
Favorite
78
Investigating for Baclofen Pump Failure in a Case of Severe Rhabdomyolysis
Favorite
79
Limited Utility of Benzodiazepines in Chronic Pain Management
Favorite
80
A close association of pain freedom with freedom from most bothersome symptom and from migraine-related functional disability in lasmiditan studies SAMURAI and SPARTAN
Favorite
81
Prescribing NSAIDs/COX-2s in patients having osteoarthritis is associated with both negative clinical outcomes and higher costs
Favorite
82
Seeking Care, Diagnosis, and Acute Prescription for Migraine Among Those with Headache-Related Disability: Results of the OVERCOME Study
Favorite
83
Impact Of Inpatient Pain Pharmacists E-consults On Post-Discharge Morphine Equivalent Daily Doses
Favorite
84
General Safety and Tolerability of Subcutaneous Tanezumab for the Treatment of Osteoarthritis: A Pooled Analysis of Randomized, Placebo-Controlled Trials
Favorite
85
Peripherally Induced Reconditioning of the Central Nervous System: Proposed Mechanisms for Sustained Relief of Chronic Pain with Percutaneous Peripheral Nerve Stimulation
Favorite
86
Randomized, controlled trial of lasmiditan over four migraine attacks: First attack findings
Favorite
87
Enhanced Recovery After Surgery In A Veteran Population
Favorite
88
Standing in the (Pain) Gap -- Why You Need a Clinical Social Worker in Your Primary Care/Rural Health/Rheumatology Clinic
Favorite
89
Naloxone Awareness and Perceptions in Opioid Populations(NAPOP) Study: Preliminary Results and Implications
Favorite
Back to Top
